Oxeze Turbuhaler (formoterol dry-powder inhaler)
/ AstraZeneca
- LARVOL DELTA
Home
Next
Prev
1 to 8
Of
8
Go to page
1
March 26, 2025
AVANT: Study to Assess Efficacy and Safety of Aclidinium Bromide and Aclidinium Bromide/Formoterol Fumarate in Stabile COPD Patients
(clinicaltrials.gov)
- P3 | N=1625 | Completed | Sponsor: AstraZeneca | N=1067 ➔ 1625
Enrollment change • Chronic Obstructive Pulmonary Disease • Immunology • Pulmonary Disease • Respiratory Diseases
November 28, 2023
Activation of Brown Adipose Tissue Thermogenesis in Humans Using Formoterol Fumarate (GB10)
(clinicaltrials.gov)
- P=N/A | N=12 | Completed | Sponsor: Université de Sherbrooke | Recruiting ➔ Completed | Trial completion date: Sep 2024 ➔ May 2023
Trial completion • Trial completion date • Diabetes • Genetic Disorders • Metabolic Disorders • Obesity • Type 2 Diabetes Mellitus
September 23, 2022
Activation of Brown Adipose Tissue Thermogenesis in Humans Using Formoterol Fumarate (GB10)
(clinicaltrials.gov)
- P=N/A | N=16 | Recruiting | Sponsor: Université de Sherbrooke
New trial • Diabetes • Genetic Disorders • Metabolic Disorders • Obesity • Type 2 Diabetes Mellitus
May 17, 2022
AVANT: Study to Assess Efficacy and Safety of Aclidinium Bromide and Aclidinium Bromide/Formoterol Fumarate in Stabile COPD Patients
(clinicaltrials.gov)
- P3 | N=1067 | Completed | Sponsor: AstraZeneca | Active, not recruiting ➔ Completed
Trial completion • Chronic Obstructive Pulmonary Disease • Immunology • Pulmonary Disease • Respiratory Diseases
December 10, 2021
AVANT: Study to Assess Efficacy and Safety of Aclidinium Bromide and Aclidinium Bromide/Formoterol Fumarate in Stabile COPD Patients
(clinicaltrials.gov)
- P3; N=1066; Active, not recruiting; Sponsor: AstraZeneca; Recruiting ➔ Active, not recruiting
Clinical • Enrollment closed • Chronic Obstructive Pulmonary Disease • Immunology • Pulmonary Disease • Respiratory Diseases
May 18, 2021
AVANT: Study to Assess Efficacy and Safety of Aclidinium Bromide and Aclidinium Bromide/Formoterol Fumarate in Stabile COPD Patients
(clinicaltrials.gov)
- P3; N=1060; Recruiting; Sponsor: AstraZeneca; Active, not recruiting ➔ Recruiting
Clinical • Enrollment open • Chronic Obstructive Pulmonary Disease • Immunology • Pulmonary Disease • Respiratory Diseases
January 16, 2021
Drugs for asthma.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal • Asthma • Immunology • Respiratory Diseases
September 23, 2020
Drugs for COPD.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal • Chronic Obstructive Pulmonary Disease • Infectious Disease • Tobacco Cessation
1 to 8
Of
8
Go to page
1